User profiles for B.C. Trapnell

Bruce C. Trapnell, MD

Professor of Medicine and Pediatrics, University of Cincinnati
Verified email at cchmc.org
Cited by 25210

Pulmonary alveolar proteinosis

BC Trapnell, JA Whitsett, K Nakata - New England Journal of …, 2003 - Mass Medical Soc
In acquired pulmonary alveolar proteinosis, lipids and proteins accumulate within the
alveoli because alveolar macrophages cannot catabolize surfactants. Surprisingly, alveolar …

Gm-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense

BC Trapnell, JA Whitsett - Annual review of physiology, 2002 - annualreviews.org
▪ Abstract Recent studies in transgenic mice have revealed important insights into the roles
of GM-CSF in regulation of surfactant homeostasis and lung host defense. Interruption of the …

Pulmonary alveolar proteinosis

BC Trapnell, K Nakata, F Bonella, I Campo… - Nature Reviews …, 2019 - nature.com
Pulmonary alveolar proteinosis (PAP) is a syndrome characterized by the accumulation of
alveolar surfactant and dysfunction of alveolar macrophages. PAP results in progressive …

In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium

MA Rosenfeld, K Yoshimura, BC Trapnell, K Yoneyama… - Cell, 1992 - cell.com
Direct transfer of the normal cystic fibrosis (CF) transmembrane conductance regulator (CFTR)
gene to airway epitheiium was evaluated using a replicationdeficient recombinant …

[HTML][HTML] Efficacy and safety of sirolimus in lymphangioleiomyomatosis

…, HS Lee, JP Krischer, BC Trapnell - … England Journal of …, 2011 - Mass Medical Soc
Background Lymphangioleiomyomatosis (LAM) is a progressive, cystic lung disease in
women; it is associated with inappropriate activation of mammalian target of rapamycin (mTOR) …

Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy

N Mittereder, KL March, BC Trapnell - Journal of virology, 1996 - Am Soc Microbiol
… toshev, and BC Trapnell. 1994. Evaluation of the efficacy and safety of in vitro, adenovirus-mediated
transfer of the human cystic fibrosis transmembrane conductance regulator cDNA. …

[PDF][PDF] GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU. 1

…, ZC Chroneos, M Yoshida, JA Whitsett, BC Trapnell - Immunity, 2001 - cell.com
… PU.1 protein levels in AMs in vivo and that the 2 Correspondence: bruce.trapnell@chmcc.org …
BC (2001). Alveolar macrophage deficiency in M-CSF-deficient, group B streptococcal …

Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA

CS Chu, BC Trapnell, S Curristin, GR Cutting… - Nature …, 1993 - nature.com
Trapnell, BC etal. Down-regulation of cystic fibrosis gene mRNAtranscript levels and
induction of the cystic fibrosis chloride secretory phenotype in epithelial cells by phorbol ester. J. …

Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study

…, BS Kirschner, AS Patel, D Ziring, BC Trapnell… - The Lancet, 2017 - thelancet.com
Background Stricturing and penetrating complications account for substantial morbidity and
health-care costs in paediatric and adult onset Crohn's disease. Validated models to predict …

Diffuse lung disease in young children: application of a novel classification scheme

…, AS Brody, LM Nogee, BC Trapnell… - American journal of …, 2007 - atsjournals.org
Rationale: Considerable confusion exists regarding nomenclature, classification, and
management of pediatric diffuse lung diseases due to the relative rarity and differences in the …